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Background: Streptococcus bovis is a classical etiology of endocarditis and is associated with
colonic lesions. No series of cases from Brazil has been described.
Objectives: To describe aspects of S. bovis endocarditis.
Methods: This is a case series of patients admitted to a cardiac surgery referral center, dur-
ing  the years 2005–2014. Clinical, laboratory, echochardiographic, colonoscopic, treatment,
surgical and outcome variables were studied.
Results: Nine patients with S. bovis endocarditis were included; all cases fulﬁlled the modiﬁed
Duke criteria. Incidence was 8/220 (4%) in years 2006–2014. There were seven male and
two  female patients; mean age was 56.7 years, standard deviation 13.4. All patients had
native aortic valve involvement. Presentation was subacute in 7/9 (71%). Fever was present
in  7/9 (77.7%), embolic lesions to solid organs occurred in three, and perivalvular abscess
in  two patients. All echocardiograms showed moderate to severe valvular regurgitation and
vegetations. Microcytic anemia was seen in 7/7 patients. Colonoscopy showed abnormal
ﬁndings in 7/9 (77.7%). Surgery was indicated for 6/9 patients due to acute aortic regurgitation
and left ventricular failure. All patients were discharged home.Conclusions: S. bovis most frequently affected the aortic valve of male patients. Colon disease
was frequent. Surgery was indicated frequently due to hemodynamic compromise.
©  2015 Elsevier Editora Ltda. All rights reserved.
bovis such as adenomatous polyps, hyperplastic polyps and. bovis endocarditis is a classical, but uncommon cause of
nfective endocarditis (IE). The association of S. bovis IE and
olon carcinoma has long been established. Several other
olonic, non-neoplastic conditions have been attributed to S.
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diverticular disease, adenomatous polyps predominating, cor-
responding to 53% of cases.1 These evidences have established
the need to investigate colon or liver disease in all patients
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presenting with S. bovis bacteremia and/or endocarditis. S.
bovis bacteremia is a major criterion for infective endocarditis2
and echocardiograms are mandatory in this clinical scenario.
Recent studies have suggested a new nomenclature for S.
bovis, so that S. bovis biotype I is now named Streptococcus gal-
lolyticus, biotype II.1 corresponds to Streptococcus infantarius,
and biotype II.2 to Streptococcus pasteurianus. In this respect,
the “S. bovis” most commonly associated with colonic cancer is
currently identiﬁed as S. gallolyticus biotype I; this is the species
usually isolated from blood cultures in this situation.3 How-
ever, the routine clinical microbiology laboratory still reports
“S. bovis” only.
A large case series evaluating 2781 cases of deﬁnite IE
in adults, from various sites, in the International Collabora-
tion Study on Infective Endocarditis-prospective cohort study,
in the years 2000–2005, has shown geographical differences
between the incidence of S. bovis IE.4 It corresponded to 9/597
(2%) of cases in North America, 17/254 (7%) in South America,
116/1213 (10%) of cases in Europe, and 23/717 (3%) of cases in
other sites (Africa, Middle East, Asia). Despite the reference
to 13 cases of S. bovis IE in 300 (4.3%) Brazilian patients with
IE in a series published in 1990, no analysis of this group of
patients was provided.5 Two recent Brazilian series of IE with
62 and 64 cases, respectively, did not feature S. bovis as an eti-
ologic agent.6,7 The goal of the present study was to describe
the features of a series of cases of IE in a Brazilian scenario,
establishing a comparison to what is known from the litera-
ture.
This is a prospective case series study of patients admit-
ted to Instituto Nacional de Cardiologia (INC), Rio de Janeiro,
Brazil, between the years of 2005 and 2014. Adult patients
with deﬁnite IE, according to the modiﬁed Duke criteria8 were
included. INC is a cardiac surgery referral hospital, receiving
a large number of cases with IE who  have an indication for
surgery. Ethical approval was obtained from the Ethics Com-
mittee of INC under the number 080/2005. Informed consent
was obtained for all patients. The study protocol conforms
to the ethical guidelines of the 1975 Helsinki Declaration
as reﬂected in a priori approval by the institution’s human
research committee.
Incidence of S. bovis IE was determined, as well as demo-
graphic data, clinical presentation, affected valves, routine
laboratory and echocardiographic data, complications, pres-
ence of comorbidities, associated liver or colonic disease,
surgery and mortality. Identiﬁcation of S. bovis was done by
automated methods (VITEK II system) and no biotyping was
available. Descriptive statistics, using frequencies as percent-
ages and mean and standard deviation (SD) was computed on
Excel® charts.
Nine cases of S. bovis IE were seen in the study period
(2005–2014). All cases were referred from other hospitals.
There were seven male and two female patients; age range
was 26–70 years, mean ± SD was 56.7 ± 13.4 years. All patients
presented aortic valve involvement, although two also had
the mitral valve affected and one the tricuspid valve. Clinical
presentation was subacute in 7/9 patients and acute in 2/9.In the past medical history, three patients had previous
abdominal surgery, two had chronic liver disease, three had
previous IE, two had congestive heart failure, and two had a
history of rheumatic fever. One out of six was a heavy drinker, 1 5;1  9(2):209–212
three drank “socially”; one was a smoker. Three of the nine
patients already had a previous diagnosis of colon carcinoma
(four, ﬁve and six years prior to the present episode of IE).
Fever was seen in 7/9 (77.7%), newly diagnosed
splenomegaly in two out of six patients (33.3%). Embolic
phenomena were seen in 3/9 patients (splenic infarct in one,
splenic abscess in two). Two of nine patients had intracar-
diac abscesses. No patients had persistently positive blood
cultures, persistent sepsis, or osteoarticular complications.
C-reactive protein levels were elevated in 3/7 cases (42.8%)
and erythrocyte sedimentation rate in four (57%, 4/7). Ferritin
levels were within normal range in the eight cases in whom it
was measured, although hemoglobin level was low in all 7/7
patients who it determined. Mean hemoglobin was 10.22 and
mean corpuscular volume was 77.6 ﬂ.
Transthoracic echocardiograms (TTE) were done in two
patients and transesophageal scans in seven; moderate to
severe valvular regurgitation and vegetations were seen in
all scans. Major echocardiographic criteria were present in all
patients, two by TTE and seven by TEE.
All patients were submitted to colonoscopy, and 7/9 (78%)
had abnormal ﬁndings: three colon carcinomas, four diver-
ticular disease of the colon (polyps were present in three of
these).
Antibiotic treatment was given for four to six weeks, and
consisted of penicillin in 5/9 cases, and ampicillin in 4/9; gen-
tamicin was given in combination in six cases.
Surgery was indicated in 6/9 cases due to severe aortic
regurgitation and/or heart failure.
All patients were discharged alive from the index hospital-
ization.
Table 1 summarizes the main clinical and laboratory char-
acteristics of the cases, and compares them to other published
series. Papers selected for comparison were those reporting
series of patients with S. bovis IE after the 1980s.
S. bovis group colonizes the human gastrointestinal tract.
It is present in 2.5–15% of healthy individuals and in 29–55%
of patients with inﬂammatory bowel disease and colon
carcinoma. It reaches the bloodstream by penetrating the gas-
trointestinal mucosa, which is facilitated by breaches as in
inﬂammation or neoplasia. S. bovis group accounts for approx-
imately 7% of native valve IE in non-drug users and 5% in
patients with prosthetic valve IE in the largest published series
so far.4 However, the incidence of S. bovis IE varies greatly
by geographical area, in this same report. All major series of
IE reported so far are from Europe, where incidence is above
10%.9–17 Although S. bovis features in some series of IE from
Brazil, it has not been studied as a single entity, so as to verify
differences or similarities to the literature.
IE in Brazil, a developing country, affects both young
patients, with rheumatic heart valve disease, and older
patients, who may have underlying colonic pathology. In our
institution, incidence of S. bovis IE was 4% in recent years,
which is similar to a recently published series of IE.18 This
may reﬂect the low positivity rates of blood cultures, espe-
cially because of prior antibiotic use. In Brazil, purchase of
antibiotics was restricted to medical prescription only after
2011, and over-the-counter sale of antibiotics was the rule
until then. Antibiotic use would rapidly clear S. bovis from the
bloodstream, as it is very sensitive to penicillin.6,7,19
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Table 1 – Comparison of variables from recent case series of S. bovis infective endocarditis.
A B C D E F G H I J
Brazil France France France Germany Italy Italy Spain Spain Ireland
Study period 2005–2014 1980–1991 1987–1992 1993–2001 1983–1996 1990–2003 1990–2003 1988–2005 1997–2008 2000–2009
Number of S. bovis IE 9  53 32 40 22 22 30 55 16 7
% number S. bovis/total IE 9/201 (4%) 53/482 (11%) N/D 40/206 (19%) 22/265 (8%) N/D 30/199 (15%) 55/228 (24%) N/D N/D
Age average (standard deviation) 56.7 (13.4) 60.6 (12.2) 61.3 (5) 64 (12) 67 (range
49–76)
59.5 58.6 (12.4) 66 69.5 (11.8) 70.9 (8.6)
Male, n (%) 7 (77.7%) 42 (79.2%) 27 (84%) 34 (85%) 12 (54%) 17 (77.6%) 17 (77.2%) 51 (93%) 9 (56.3%) 5 (71.4%)
Female, n (%) 2  (22.3) 11 (20.8%) 5 (15%) 6 (15%) 10 (46%) 5 (22.4%) 5 (22.8%) 4 (7%) 7 (43.6%) 2 (28.6%)
Site of infection
Native mitral valve 0 (0%) 6 (11%) N/D 7 (17%) N/D 3 (13%) 4 (13%) 10 (18%) N/D 1/7 (14%)
Native aortic valve 6 (66.6%) 26 (49%) N/D 15 (37%) N/D 9 (26%) 8 (27%) 22 (40%) N/D 0 (0%)
Native mitro-aortic valves 2 (22.2%) 18 (33%) N/D N/D N/D 7 (40%) 12 (40%) 23 (42%) N/D 1/7 (14%)
Prosthetic valve 0 (0%) 0 (0%) N/D 5 (12%) N/D 2 (10.0%) 3 (10%) 0 (0%) 10/16 (62.5%) 3/7 (43%)
Tricuspid valve 0 (0%) 1 (1.8%) N/D 2 (5%) N/D 1 (6.7%) 2 (7%) 0 (0%) N/D 0 (0%)
Clinical aspects
Heart failure 1 (11.1%) 35/53 (66%) ND 8/40 (20%) 7/22 (32%) ND 12 (40%) 15 (27%) ND 2 (28.6%)
Embolism 2/6 (33.3%) 22/53 (42%) ND 22 (55%) 2/22 (9%) ND ND 21 (38%) 2 (13%) 0
Surgery 6 (66.6%) 41/53 (77%) ND 22 (55%) 16/22 (73%) ND 22 (73%) 19 (29%) 6 (38%) 2 (28.6%)
Colonoscopy
Patients with colonoscopy 9 (100%) 40/53 (75%) 32/32 40/40 ND 18/22 (82%) 27/30 (90%) 46/55 (84%) 15/16 (94%) 7 (100%)
Patients with positive colonoscopy 7 (77.7%) 27 (67%) 18 (56.2%) 22 (56%) ND 8 (%) 4 (15%) 29 (63%) 14 (93.0%) 6 (85.7%)
In-hospital mortality 0 (0%) 4 (7.5%) N/D 1 (2%) ND ND 5 (16.7%) 12 (22%) 2 (12.5%) 0 (0%)
A – present study, adapted from references: B – Ballet et al. (1995); C – Bruno Hoen et al. (1994); D – Pergola et al. (2001); E – Kupferwasser et al. (1998); F – Tripodi et al. (2005); G – Tripodi et al. (2004); H
– Corredoira et al. (2008); I – Fernández-Ruiz et al. (2010); J – Fitzmauric et al. (2013).
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S. bovis IE usually affects patients older than 60 years; mean
age in our study was 56.7 years. It more  often affects the aor-
tic valve, and this was the case in all our patients, although
there is a referral bias, since INC is a surgical hospital and
hemodynamic compromise is more  severe when the aortic
valve is affected. However, aortic valve involvement, alone
or combined with the mitral valve, with high rates (55–77%)
of surgery indication was seen in larger series from France,
Italy and Germany.9–12 A strong association with colonic can-
cer has been recognized for S. bovis biotype I, or S. gallolyticus.20
However, colonic lesions found in association with S. bovis IE
may be neoplastic or non-neoplastic. It is believed the colonic
lesion facilitates colonization by S. bovis, provides a physi-
cal breach in the mucosa, and therefore makes bacteremia
more likely. On the other hand, S. bovis may have tumor
promoting properties to colonic lesions, via proinﬂammatory
(cyclo-oxygenase 2) pathways. Incidence of colon carcinoma
and IE by S. bovis has been estimated as 18–62%, and it was
present in three out of nine patients in this series. Bacteremia
or endocarditis may precede or follow colon carcinoma. Three
of the nine patients in our study already had a previous diag-
nosis of colonic cancer.
A recent meta-analysis was conducted to determine the
risk associated with Streptococcus bovis infection and the occur-
rence of colorectal neoplasia.21 Studies included were those
on S. bovis septicemia, S. bovis endocarditis and S. bovis fecal
carriage. Overall, the presence of S. bovis infection was found
to be signiﬁcantly associated with the presence of colorectal
neoplasia. S. bovis endocarditis showed the strongest associ-
ation in analyses of case-control studies and case series (OR
14.54, 95% CI 5.66–37.35).
Despite the small number of cases in this series, it is the
ﬁrst series of S. bovis IE describing patients from Latin America.
The clinical proﬁle of S. bovis IE and associated colon disease
was similar to other recently published series from Europe.
Similarities are the mean age of 60 years, the predominance
of aortic valve involvement, high proportion of surgery indi-
cation, and the ﬁnding of colonic pathology in most patients.
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